Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetesMohammad Alhadj Ali, Colin Dayan, YF Liu et al.|Science Translational Medicine|2017Cited by 215
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluationLeila Rooshenas, Wei Tan, Lauren J Scott et al.|Journal of Clinical Epidemiology|2018Cited by 98
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter Taylor, Jan Dutz, Kimberly S. Collins et al.|The Lancet Diabetes & Endocrinology|2023Cited by 58
A systematic review and meta‐analysis of interventions to preserve insulin‐secreting β‐cell function in people newly diagnosed with type 1 diabetes: Results from intervention studies aimed at improving glucose controlParth Narendran, David Moore, Malcolm J Price et al.|Diabetic Medicine|2021Cited by 11
A systematic review and network meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from randomised controlled trials of immunomodulatory therapiesSophie Beese, Parth Narendran, Malcolm J Price et al.|BMC Medicine|2025Cited by 10